Cargando…

PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition

Breast cancer is the leading cause of females characterized by high invasive potential. It is necessary to explore the underlying mechanism of breast cancer metastases and to find specific therapeutic targets. PKM2 is considered a new biomarker of cancer with upregulated expression in tumor tissue....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Hui, Zhang, Longxiao, Chen, Yuan, Zhou, Chengjun, Wang, Xiao, Wang, Dehai, Liu, Zhenzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718057/ https://www.ncbi.nlm.nih.gov/pubmed/33294309 http://dx.doi.org/10.1155/2020/8396023

Ejemplares similares

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression
por: Li, Linna, et al.
Publicado: (2014)

Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin
por: Liu, Xiao, et al.
Publicado: (2021)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

Mixed lineage kinase ZAK promotes epithelial–mesenchymal transition in cancer progression
por: Li, Linna, et al.
Publicado: (2018)

Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2 Signaling Pathway
por: Lei, Rui, et al.
Publicado: (2019)

Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial–mesenchymal transition via Wnt/β-catenin signaling
por: Lin, Yanzhu, et al.
Publicado: (2018)

Atg7 inhibits Warburg effect by suppressing PKM2 phosphorylation resulting reduced epithelial-mesenchymal transition
por: Feng, Yanling, et al.
Publicado: (2018)

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer
por: Wang, Qing-Shan, et al.
Publicado: (2015)

HER4 promotes the progression of colorectal cancer by promoting epithelial-mesenchymal transition
por: Jia, Xiaojing, et al.
Publicado: (2020)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression
por: Zhang, Xiao, et al.
Publicado: (2020)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer
por: Yin, Kailin, et al.
Publicado: (2017)

Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma
por: Thiery, JP, et al.
Publicado: (2011)

RNF8 promotes epithelial-mesenchymal transition of breast cancer cells
por: Kuang, Jingyu, et al.
Publicado: (2016)

Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
por: Jiang, Zong-Sheng, et al.
Publicado: (2017)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

Metabolic switch and epithelial–mesenchymal transition cooperate to regulate pluripotency
por: Sun, Hao, et al.
Publicado: (2020)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
por: Fenizia, Claudio, et al.
Publicado: (2019)

PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Leng, Shusheng, et al.
Publicado: (2017)

Autophagy regulates hepatocyte identity and epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions promoting Snail degradation
por: Grassi, G, et al.
Publicado: (2015)

NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer
por: Kong, Chenfei, et al.
Publicado: (2011)

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells
por: Wang, Tong, et al.
Publicado: (2015)

MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer
por: Liang, Yong-Jun, et al.
Publicado: (2013)

Gli promotes tumor progression through regulating epithelial-mesenchymal transition in non–small-cell lung cancer
por: Jiang, Long, et al.
Publicado: (2020)

Up-frameshift Protein 1 Promotes Tumor Progression by Regulating Apoptosis and Epithelial–Mesenchymal Transition of Colorectal Cancer
por: Chen, Binlie, et al.
Publicado: (2021)

Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition
por: Wen, Jialiang, et al.
Publicado: (2020)

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
por: Huang, Yuting, et al.
Publicado: (2014)

ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3
por: Yu, Ting-ting, et al.
Publicado: (2021)

Metadherin regulates epithelial–mesenchymal transition in carcinoma
por: Wang, Zhao, et al.
Publicado: (2016)

The Role and Significance of Wnt5a in Regulating Epithelial–Mesenchymal Transition in Endometrioid Adenocarcinoma
por: Yang, Ningning, et al.
Publicado: (2021)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

Epithelial-Mesenchymal Transition and Breast Cancer
por: Wu, Yanyuan, et al.
Publicado: (2016)

LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition
por: Li, Jing, et al.
Publicado: (2019)

Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
por: Li, Hui, et al.
Publicado: (2016)

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
por: Bednarczyk, Robert B., et al.
Publicado: (2018)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hfufncc1ggns349b2818dnkc2k